Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.59 |
| ▸ | IDO1 | P14902 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | CA5A | P35218 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11879263 | 0.98 | EPHX1 (0.57) | EPHX1EPHX2IDO1GAACA2 | |
| Bicarbonate SCHEMBL7359619 | 0.93 | EPHX1 (0.61) | EPHX1EPHX2IDO1GAACA2 | |
| Nitric Acid SCHEMBL4490937 | 0.88 | EPHX1 (0.51) | EPHX1EPHX2IDO1GAACA2 | |
| SCHEMBL891282 | 0.85 | EPHX1 (0.52) | EPHX1EPHX2IDO1GAACA2 | |
| Hydrochloric Acid SCHEMBL9668292 | 0.83 | EPHX1 (0.50) | EPHX1EPHX2IDO1GAACA2 | |
| Hydrochloric Acid SCHEMBL11511126 | 0.82 | ALDH1A1 (0.45) | EPHX1EPHX2IDO1GAACA2 | |
| SCHEMBL30496721 | 0.82 | MAPT (0.57) | EPHX1EPHX2IDO1GAACA2 | |
| SCHEMBL11879529 | 0.82 | CNR2 (0.43) | EPHX1EPHX2IDO1GAACA2 | |
| SCHEMBL18286554 | 0.82 | GAA (0.57) | GAACA2ALDH1A1MAPTNPC1 | |
| SCHEMBL10310181 | 0.82 | MEN1 (0.62) | CA2ALDH1A1MAPTNPC1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120006519-A | Ultraviolet aging resistant car cover and preparation method thereof | 安徽萨克赛斯纺织科技有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-115957589-B | Desulfurization filler and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-117106451-B | Low-damage semiconductor silicon etching solution, preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-117106451-A | Low-damage semiconductor silicon etching solution, preparation method and application thereof | 浙江奥首材料科技有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-115957812-A | Modified hollow ceramic fiber and preparation and application thereof | 中国石油化工股份有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-115957589-A | Desulfurization filler and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-111019121-A | Preparation method of guanidine polymer ionic liquid | 石家庄学院 | 2020-04-17 | — | — | CN | claimed |
| CN-110804179-A | High-molecular ionic liquid with good film forming property and long-term antibacterial activity and application thereof | 石家庄学院 | 2020-02-18 | — | — | CN | claimed |
| CN-110804198-A | Preparation method of antibacterial cellulose degradable composite membrane | 石家庄学院 | 2020-02-18 | — | — | CN | claimed |
| CN-106380598-B | A kind of synthetic method of degradation property and its application | 石家庄学院 | 2018-10-19 | — | — | CN | claimed |
| EP-1686990-B1 | 2-GUANIDINYLIMIDAZOLIDINEDIONE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | US ARMY MED RES MAT COMMAND (US) | 2012-09-19 | — | — | EP | claimed |
| EP-1686990-A4 | 2-GUANIDINYLIMIDAZOLIDINEDIONE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | US ARMY MED RES MAT COMMAND (US) | 2009-06-03 | — | — | EP | claimed |
| US-7101902-B2 | 2-guanidinylimidazolidinedione compounds and methods of making and using thereof | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2006-09-05 | — | — | US | claimed |
| EP-1686990-A2 | 2-GUANIDINYLIMIDAZOLIDINEDIONE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | U.S. Army Medical Research and Materiel Command (US) | 2006-08-09 | — | — | EP | claimed |
| WO-2005072082-A2 | 2-GUANIDINYLIMIDAZOLIDINEDIONE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND (US) | 2005-08-11 | — | — | WO | claimed |
| US-20050148645-A1 | 2-Guanidinylimidazolidinedione compounds and methods of making and using thereof | ARMY, UNITED STATES | 2005-07-07 | — | — | US | claimed |
| US-3976787-A | VASOCONSTRICTION | ARMOUR PHARMACEUTICAL COMPANY (US) | 1976-08-24 | — | — | US | claimed |
| US-12595279-B2 | Modified nucleoside and synthetic methods thereof | Stemirna Therapeutics Co., Ltd. (CN) | 2026-04-07 | — | — | US | disclosed |
| US-3976643-A | FROM AN ANILINE AND CYANAMIDE | WILLIAM H. RORER, INC. (US) | 1976-08-24 | — | — | US | disclosed |
| US-3976787-A | VASOCONSTRICTION | ARMOUR PHARMACEUTICAL COMPANY (US) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050148645-A1 | 2-Guanidinylimidazolidinedione compounds and methods of making and using thereof | GUCY1B2, GUCY1A2, AGK | EPHX1 2002/4885EPHX2 1468/4885IDO1 1451/4885 |
| US-12595279-B2 | Modified nucleoside and synthetic methods thereof | RNMT, NSUN2, RNGTT | EPHX1 3996/4885EPHX2 2722/4885IDO1 3197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.